Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/11/2026

Maternal Health Benefits of Breastfeeding

Cancer Risk Reduction

  • Breastfeeding lowers the risk of breast cancer by approximately 19% (OR 0.81, 95 % CI 0.77‑0.86); the protective effect increases with longer cumulative duration of lactation. The American College of Obstetricians and Gynecologists notes this dose‑response relationship. 1, 2
  • Breastfeeding reduces ovarian cancer risk by about 30% (OR 0.70, 95 % CI 0.64‑0.75). The European League Against Rheumatism (EULAR) highlights this substantial protective effect. 1

Metabolic & Cardiovascular Benefits

  • Breastfeeding is associated with a 32% reduction in the incidence of type 2 diabetes (OR 0.68, 95 % CI 0.57‑0.82); the benefit is especially pronounced in women with a prior history of gestational diabetes. The American Diabetes Association emphasizes this metabolic advantage. 1, 3
  • Lactating mothers experience lower rates of hypertension and cardiovascular disease, reflecting favorable metabolic changes during lactation (e.g., improved lipid profiles). 3

Reproductive & Societal Benefits

  • Exclusive breastfeeding provides a natural contraceptive effect that lengthens birth spacing, contributing to improved maternal reproductive health. 4, 5
  • The American Academy of Pediatrics recommends exclusive breastfeeding for about 6 months and continued breastfeeding for 2 years or longer to maximize maternal health benefits. 1, 2
  • Extending breastfeeding beyond 12 months further decreases maternal rates of type 2 diabetes, hypertension, breast cancer, and ovarian cancer. 2
  • The protective effects are cumulative: each additional month of breastfeeding adds incremental protection against chronic diseases. 2, 4, 5

Clinical Implementation Considerations

  • Healthcare providers should explicitly communicate that breastfeeding is a medical priority and offer non‑judgmental support, particularly for mothers who wish to continue beyond the first year. 2
  • Women with pre‑existing dyslipidemia or diabetes should maintain appropriate monitoring during lactation, although lactation‑related metabolic shifts are generally beneficial for long‑term cardiovascular health. 3

Policy, Workplace, and Economic Impact

  • Full‑time employment is consistently linked to shorter breastfeeding durations; in the United States, breastfeeding rates drop sharply between 2–3 months when mothers return to work. The American Heart Association reports these trends. 6, 2
  • Supportive workplace policies and public infrastructure (e.g., lactation rooms, flexible scheduling) significantly extend breastfeeding duration, thereby enhancing maternal health outcomes. 6, 2
  • The aggregate health improvements for mothers (and infants) translate into measurable societal economic benefits through reduced healthcare expenditures and enhanced population health. 4, 5

Maternal Health Benefits and Considerations of Breastfeeding

Cancer Risk Reduction

  • Breastfeeding lowers the risk of breast cancer by approximately 19% (OR 0.81, 95 % CI 0.77‑0.86), with greater protection observed the longer the cumulative lactation period. 7
  • Breastfeeding reduces the risk of ovarian cancer by about 30% (OR 0.70, 95 % CI 0.64‑0.75); the protective effect strengthens with increased duration of nursing. 7
  • Breastfeeding is associated with a modest reduction in endometrial cancer risk (OR 0.89, 95 % CI 0.81‑0.98). 8

Metabolic and Cardiovascular Benefits

  • Women who breastfeed experience a 32% lower risk of developing type 2 diabetes (OR 0.68, 95 % CI 0.57‑0.82), especially those with a history of gestational diabetes. 7
  • Breastfeeding is linked to lower hypertension prevalence in mothers, reflecting favorable metabolic adaptations during lactation. 8

Duration Recommendations for Maximizing Maternal Health

  • The American Academy of Pediatrics recommends exclusive breastfeeding for about 6 months, followed by continued nursing for 2 years or longer to achieve optimal maternal health benefits. 8
  • Extending breastfeeding beyond 12 months provides additional reductions in maternal rates of type 2 diabetes, hypertension, breast cancer, and ovarian cancer. 8

Absolute Contraindications to Breastfeeding (U.S.)

  • HIV infection
  • Human T‑cell lymphotropic virus type I or II infection
  • Untreated brucellosis
  • Suspected or confirmed Ebola virus disease
  • Classic galactosemia in the infant

Relative Contraindications and Counseling

  • Tobacco use: Mothers who smoke should receive strong cessation counseling; if they continue, they should avoid smoking while nursing and wait until after feeding before smoking again. 9
  • Alcohol consumption: Moderate intake (up to one standard drink per day) is considered safe provided the mother waits at least two hours before nursing or expressing milk. 9
  • Medications: The majority of maternal medications are compatible with breastfeeding; clinicians should consult the Drugs and Lactation Database (LactMed) for specific safety information. 9

Clinical Management Considerations

  • Lactation markedly increases insulin sensitivity, raising the risk of overnight hypoglycemia in mothers with diabetes; insulin regimens should be adjusted accordingly. 7
  • Women who continue breastfeeding beyond the first year may feel socially unsupported; approximately 38 % who perceive their provider as unsupportive switch pediatric providers, underscoring the need for non‑judgmental support. 8
  • Most maternal infections do not preclude breastfeeding; breast milk conveys antibodies, and standard infection‑control measures (hand hygiene, masking) are recommended when the mother is ill. 8